Of the seven patients that we identified who had potential false positive fasting plasma glucagon concentrations, three had diabetes mellitus, two had end stage renal failure and one had chronic pancreatitis (Table 3). This evidence concerns the gene GCG and stage 5 chronic kidney disease.